He has received his Doctoral training in Pharmaceutical Sciences at the Hebrew University of Jerusalem and is pursuing his Post-doctoral studies at CHOP. In 2009, he joined the Faculty of Perelman School of Medicine at the University of Pennsylvania. His research focuses on development and evaluation of biodegradable nanocarriers for targeted delivery of drugs, gene vectors and cells for cardiovascular disease applications and cancer therapy.